Exploring Environmental Risk Factors for Disease Progression in Multiple Sclerosis and Amyotrophic Lateral Sclerosis

A special issue of Sclerosis (ISSN 2813-3064).

Deadline for manuscript submissions: 10 December 2024 | Viewed by 1288

Special Issue Editors


E-Mail Website
Guest Editor
1. Scientific Direction, Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy
2. Istituto di Ricerche Farmacologiche “Mario Negri”, 20156 Milano, Italy
Interests: risk factors; prognostic factors; guidelines; neuroepidemiology; multiple sclerosis; amyotrophic lateral sclerosis; alcohol-related diseases

E-Mail Website
Guest Editor
Division of Clinical Neuroscience, Section of Clinical Neurology, University of Nottingham, Nottingham NG7 2UH, UK
Interests: neuroinflammation; multiple sclerosis; neuromodulation

Special Issue Information

Dear Colleagues,

While the role of environmental factors in increasing the risk of developing multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) is partially known, growing evidence suggests that they also significantly contribute to disease progression in both conditions. By dedicating a Special Issue to this topic, we can bring together experts from various disciplines to share their research findings and create a robust knowledge base regarding the environmental risk factors involved.

The objective of this Special Issue is to foster a comprehensive understanding of the environmental risk factors implicated in the progression of both MS and ALS. By comparing and contrasting the similarities and differences between the two diseases, we aim at identifying shared mechanisms and discovering potential avenues for preventive strategies.

Main Themes:

  1. Common Environmental Risk Factors: Investigate shared environmental factors that have been associated with disease progression in both MS and ALS. These include toxic exposures, pollution, occupational hazards, smoking, physical activity, diet/nutrition, and others.
  2. Disease-Specific Environmental Risk Factors: Discuss environmental factors that are more specific to either MS or ALS, exploring their different role in disease onset and progression and potential mechanisms of action.
  3. Biomarkers and Mechanisms: Explore biomarkers or underlying mechanisms that are implicated in both diseases, shedding light on potential common pathways that link environmental exposures to disease progression. These may include immune oxidative stress, neuroinflammation, and mitochondrial dysfunction.
  4. Preventive Strategies and Interventions: Highlight the potential of these identified environmental risk factors as targets for therapeutic interventions and strategies to slow disease progression in both MS and ALS. This may involve lifestyle modifications, public health policies, pharmacological interventions, and innovative technologies.

This Special Issue will consist of expert reviews, original research articles, and perspective pieces. We aim to involve researchers and clinicians from various fields such as neurology, epidemiology, toxicology, immunology, and environmental health.

This Special Issue will provide a platform for the synthesis and dissemination of evidence regarding environmental risk factors for disease progression in MS and ALS. By highlighting similarities and differences, we can develop a more comprehensive understanding of the complex interactions between genetics and the environment in disease progression. Ultimately, this knowledge will pave the way for preventive measures, early interventions, and personalized treatments for these devastating neurological disorders.

Dr. Maurizio A. Leone
Dr. Radu Tanasescu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sclerosis is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • environmental risk factors
  • multiple sclerosis
  • amyotrophic lateral sclerosis
  • disease onset and progression
  • environmental exposures

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 575 KiB  
Article
Diet-Induced Changes in Functional Disability among People with Multiple Sclerosis: A Secondary Pooled Analysis of Two Randomized Controlled Pilot Trials
by Allison R. Groux, Elizabeth S. Walker, Farnoosh Shemirani, Jennifer E. Lee, Amanda K. Irish, Linda M. Rubenstein, Linda G. Snetselaar, Warren G. Darling, Terry L. Wahls and Tyler J. Titcomb
Sclerosis 2024, 2(3), 156-165; https://doi.org/10.3390/sclerosis2030011 - 4 Jul 2024
Viewed by 976
Abstract
Emerging evidence links dietary interventions to favorable multiple sclerosis (MS) outcomes; however, evidence for the efficacy of dietary interventions on functional disability remains sparse. Data from two 12-week, randomized, controlled pilot trials were pooled to investigate the efficacy of a modified Paleolithic diet [...] Read more.
Emerging evidence links dietary interventions to favorable multiple sclerosis (MS) outcomes; however, evidence for the efficacy of dietary interventions on functional disability remains sparse. Data from two 12-week, randomized, controlled pilot trials were pooled to investigate the efficacy of a modified Paleolithic diet (Paleo) on functional disability, as assessed by the MS Functional Composite (MSFC), among people diagnosed with MS. Pooled baseline-referenced MSFC scores were calculated from the nine-hole peg test (NHPT), timed 25-foot walk (T25FW), and Paced Auditory Serial Addition Test (PASAT) Z-scores. There was no significant difference in the mean change in MSFC scores between groups (p = 0.07). In the Paleo group, a significant increase was observed in the MSFC scores (p = 0.03), NHPT (p < 0.001), and PASAT (p = 0.04) Z-scores at 12 weeks, indicating reduced functional disability compared to baseline values. No significant changes were observed within the Control group. Study-specific differences in the MSFC changes between groups were observed. Functional disability was reduced compared to the baseline in the Paleo group, possibly depending on MS type. These results provide preliminary observations on the efficacy of a modified Paleolithic diet for reducing or maintaining functional disability in MS. Full article
Show Figures

Figure 1

Back to TopTop